Increased Antitumor Activity of Bevacizumab in Combination With Hypoxia Inducible Factor-1 Inhibition

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-09-0274
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Targeting Hypoxia-Inducible Factor-1α (HIF-1α) in Combination With Antiangiogenic Therapy: A Phase I Trial of Bortezomib Plus Bevacizumab

Oncotarget
Oncology
2014English

Identification of Novel Small Molecule Inhibitors of Hypoxia-Inducible Factor-1 That Differentially Block Hypoxia-Inducible Factor-1 Activity and Hypoxia-Inducible Factor-1α Induction in Response to Hypoxic Stress and Growth Factors

Cancer Research
Cancer ResearchOncology
2005English

Increased Expression of Hypoxia-Inducible Factor 1α in Coeliac Disease

Pediatric Research
Child HealthPediatricsPerinatology
2010English

Rac1 Activity Is Required for the Activation of Hypoxia-Inducible Factor 1

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Direct Inhibition of Hypoxia-Inducible Transcription Factor Complex With Designed Dimeric Epidithiodiketopiperazine

Journal of the American Chemical Society
BiochemistryColloidCatalysisChemistrySurface Chemistry
2009English

Mucosal Protection by Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibition

Gastroenterology
HepatologyGastroenterology
2008English

Transforming Growth Factor Β1 Induces Hypoxia-Inducible Factor-1 Stabilization Through Selective Inhibition of PHD2 Expression

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Regulation of Metabolism by Hypoxia-Inducible Factor 1

Cold Spring Harbor Symposia on Quantitative Biology
BiochemistryGeneticsMolecular Biology
2011English

Hypoxia Inducible Factor

2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy